SEPTIN14P1

Across TCGA pan-cancer cohorts, SEPTIN14P1 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated SEPTIN14P1 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher SEPTIN14P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SEPTIN14P1 expression acts as an unfavorable survival marker.

LUAD, SKCM, and PAAD are the cancer types where SEPTIN14P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	II,III,IV	0.109	0.750	<.001	54	view →
SKCM	DFS	Tertile	IV	0.016	0.454	<.001	18	view →
PAAD	OS	Tertile	II,III,IV	0.213	0.556	.014	18	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	14	view →
LIHC	DFS	Tertile	All	0.153	0.433	.038	9	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

SEPTIN14P1–LUAD (OS)

Open the LUAD breakdown →